Search Results
Results found for "Elizabeth Johnstone"
- Dr. Kevin Pfleger and Dr. Elizabeth Johnstone were awarded one of the 2022 Diabetes Research...
Elizabeth Johnstone were awarded one of the 2022 Diabetes Research Grants at the World Diabetes Day Breakfast "Congratulations to Perkins Professor Kevin Pfleger and Dr Elizabeth Johnstone who were awarded one of
- Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc. has...
November 2021 Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc today announced that Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, has successfully completed Phase 1 studies in Japan with JNJ-40411813 (ADX71149).
- GPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical Development
Previous companies worked at include OrthoBiotech (OBI), a division of Johnson & Johnson and GlaxoSmithKline
- 📰 GPCR Weekly News, January 1 to 7, 2024
Anthony Johnson as President/CEO! Save the dates: February 8 - 29: Join Dr.
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
.; Johnsson, K. doi.org/10.1038/nmeth.1213 . (23) Keppler, A.; Gendreizig, S.; Gronemeyer, T.; Pick, H.; Vogel, H.; Johnsson
- Structural landscape of the Chemokine Receptor system
stability of the salt bridge depends on the position of NH2, which is most stable at position 1 (Wasilko, Johnson
